Spanish Red Biotech Pipeline

FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria)

New antigenic trigger

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Method for the diagnosis and/or treatment of atherosclerosis
Phase: 1Non Regulatory Preclinical